In addition, BBR treatment of T2D mice inhibited the expression of liver SREBP-1, a transcription factor required for lipogenic gene expression, and expression of liver FAS-1 a key protein involved in fatty acid synthesis. The gene discussed is FAS; the disease is type 2 diabetes mellitus.